156 related articles for article (PubMed ID: 31559065)
21. Minimally invasive Ivor-Lewis esophagectomy for esophageal cancer.
Eroğlu A; Daharlı C; Bilal Ulaş A; Keskin H; Aydın Y
Turk Gogus Kalp Damar Cerrahisi Derg; 2022 Jul; 30(3):421-430. PubMed ID: 36303687
[TBL] [Abstract][Full Text] [Related]
22. Combined laparoscopic and thoracoscopic Ivor Lewis esophagectomy for esophageal cancer: initial experience from China.
Li H; Hu B; You B; Miao JB; Fu YL; Chen QR
Chin Med J (Engl); 2012 Apr; 125(8):1376-80. PubMed ID: 22613638
[TBL] [Abstract][Full Text] [Related]
23. Minimally Invasive
Knitter S; Andreou A; Hofmann T; Chopra S; Denecke C; Thuss-Patience PC; Kröll D; Bahra M; Schmelzle M; Pratschke J; Biebl M
Anticancer Res; 2021 Jul; 41(7):3499-3510. PubMed ID: 34230145
[TBL] [Abstract][Full Text] [Related]
24. McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis.
van Workum F; Berkelmans GH; Klarenbeek BR; Nieuwenhuijzen GAP; Luyer MDP; Rosman C
J Thorac Dis; 2017 Jul; 9(Suppl 8):S826-S833. PubMed ID: 28815080
[TBL] [Abstract][Full Text] [Related]
25. Incidence and management of chylothorax after Ivor Lewis esophagectomy for cancer of the esophagus.
Brinkmann S; Schroeder W; Junggeburth K; Gutschow CA; Bludau M; Hoelscher AH; Leers JM
J Thorac Cardiovasc Surg; 2016 May; 151(5):1398-404. PubMed ID: 26936011
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Long-term Quality of Life in Patients with Esophageal Cancer after Ivor-Lewis, Mckeown, or Sweet Esophagectomy.
Yang YS; Shang QX; Yuan Y; Wu XY; Hu WP; Chen LQ
J Gastrointest Surg; 2019 Feb; 23(2):225-231. PubMed ID: 30298418
[TBL] [Abstract][Full Text] [Related]
27. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
28. Short-term outcomes of minimally invasive Ivor-Lewis esophagectomy for esophageal cancer.
Xie MR; Liu CQ; Guo MF; Mei XY; Sun XH; Xu MQ
Ann Thorac Surg; 2014 May; 97(5):1721-7. PubMed ID: 24657031
[TBL] [Abstract][Full Text] [Related]
29. [Laparothoracoscopic Ivor Lewis esophagectomy with esophageal-gastric intrapleural anastomosis].
Allakhverdyan AS; Anipchenko SN
Khirurgiia (Mosk); 2020; (9):5-13. PubMed ID: 33029996
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy comparison between two-field and three-field lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lin D; Ye T; Ma L; Shao L; Song Z; Jiang S; Xiang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):990-994. PubMed ID: 27680065
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy comparison of two surgical procedures to treat middle thoracic esophageal carcinoma.
Yu Y; Wang Z; Liu XY; Zhu XF; Chen QF
World J Surg; 2010 Feb; 34(2):272-6. PubMed ID: 20041250
[TBL] [Abstract][Full Text] [Related]
32. Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy for squamous cell carcinoma of the lower thoracic esophagus.
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
World J Gastroenterol; 2008 Aug; 14(32):5084-9. PubMed ID: 18763294
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of modified thoraco-laparoscopic Ivor-Lewis versus traditional thoraco-laparoscopic Ivor-Lewis for esophageal cancer: Propensity score-matched analysis.
Hong Z; Gou W; Lu Y; Wu X; Sheng Y; Cui B; Bai X; Jin D; Gou Y
Front Oncol; 2022; 12():1076014. PubMed ID: 36733352
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of postoperative quality of life in patients with middle thoracic esophageal carcinoma undergoing minimally invasive Ivor-Lewis esophagectomy].
Zhang J; Xu M; Guo M; Mei X; Liu C
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Sep; 17(9):915-9. PubMed ID: 25273663
[TBL] [Abstract][Full Text] [Related]
35. Alternative method for jejunostomy in Ivor-Lewis esophagectomy.
Gong L; Yan B; Chen Y; Wang M; Zhang Q; Hui C; Wang C
Thorac Cancer; 2015 May; 6(3):296-302. PubMed ID: 26273375
[TBL] [Abstract][Full Text] [Related]
36. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
[TBL] [Abstract][Full Text] [Related]
37. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
38. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy.
Chen G; Wang Z; Liu XY; Liu FY
World J Surg; 2007 May; 31(5):1107-14. PubMed ID: 17426905
[TBL] [Abstract][Full Text] [Related]
39. Ivor Lewis vs Mckeown esophagectomy: analysis of operative outcomes from the ACS NSQIP database.
Sabra MJ; Alwatari YA; Wolfe LG; Xu A; Kaplan BJ; Cassano AD; Shah RD
Gen Thorac Cardiovasc Surg; 2020 Apr; 68(4):370-379. PubMed ID: 31933140
[TBL] [Abstract][Full Text] [Related]
40. [Comparative analysis on the classic and modified Ivor-Lewis procedure in the treatment of mid-low thoracic esophageal carcinoma].
Zhen FX; Luo JH; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Dec; 16(12):1180-2. PubMed ID: 24369401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
